Company
iTeos Therapeutics
iTeos Therapeutics has 6 drugs tracked on RxWires: 1 in Phase 2, 1 in Phase 1/2, 4 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| inupadenant | Phase 2 | Metastatic NSCLC - Non-Small Cell Lung Cancer |
| EOS-448 | Phase 1/2 | Advanced Cancer |
| EOS301984 | Phase 1 | Advanced Solid Tumors |
| EOS100850 | Phase 1 | Solid Tumor, Adult |
| EOS884448 | Phase 1 | Multiple Myeloma |
| EOS006215 | Phase 1 | Selected Advanced Solid Tumors |
Latest
No recent events.
Follow iTeos Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.